Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03100760 · ClinicalTrials.gov registry record
Urease Breath Test for Rapid Characterization of Pneumonia
A clinical trial of Pneumonia, Bacterial, sponsored by University of New Mexi.
- Completed
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT03100760: Completed study of Pneumonia, Bacterial, sponsored by University of New Mexi.
NCT03100760 is a study of Pneumonia, Bacterial that has completed, run by University of New Mexi. The registered enrollment target is 75 participants, below the 1,338-participant average among 7 other Pneumonia, Bacterial trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03100760, a study of Pneumonia, Bacterial, has completed, sponsored by University of New Mexi.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a Phase 1, open label, evaluation of a 13C-urea breath test for the detection of urease-producing bacteria in patient with pneumonia in the emergency department.
Primary Outcome
Any untoward medical occurrence associated with the use of a drug in humans, whether or not considered drug related.
Conditions Studied
Interventions
- DEVICE 13C-urea breath test
Study Locations (1)
Michigan
- Henry Ford Health System - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2020-06-04 |
What the finished NCT03100760 record still lists
NCT03100760 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,338-participant average among 7 other Pneumonia, Bacterial trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Pneumonia, Bacterial appearing as the primary indexed condition, and to 1 intervention - of which 13C-urea breath test is the first listed.
NCT03100760 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03100760 about?
NCT03100760 is a clinical study titled "Urease Breath Test for Rapid Characterization of Pneumonia". This is a Phase 1, open label, evaluation of a 13C-urea breath test for the detection of urease-producing bacteria in patient with pneumonia in the emergency department.
What is the current status of trial NCT03100760?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2017-05-01. Estimated completion is 2020-06-04.
What conditions does trial NCT03100760 study?
This clinical trial studies the following conditions: Pneumonia, Bacterial.
What interventions are being tested in trial NCT03100760?
The interventions under investigation include: 13C-urea breath test (DEVICE).
Who is sponsoring clinical trial NCT03100760?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03100760 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumonia, Bacterial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia
ACTIVE NOT RECRUITING · Phase 2
-
Discharge Stewardship in Children's Hospitals
ACTIVE NOT RECRUITING · NA
-
Pneumonia Direct Pilot
COMPLETED
-
Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
COMPLETED · Phase 2
-
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
COMPLETED · Phase 2
-
CTTI Risk Factors for HABP/VABP Study
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI